Literature DB >> 29649469

Phosphatidylserine Is Not Just a Cleanup Crew but Also a Well-Meaning Teacher.

Fiona Y Glassman1, Jennifer L Schneider1, Radha Ramakrishnan1, Robert K Dingman1, Murali Ramanathan1, Richard B Bankert2, Sathy V Balu-Iyer3.   

Abstract

Phosphatidylserine (PS) exposure during apoptosis leads to silent clearance of cells without adverse immune reactions to self-proteins. Given the biological functions of PS in cellular cleanup and global immunosuppression, we hypothesized that administration of PS-protein complexes would reduce immunogenicity. Here, we report that exposing Pompe disease mice to acid alpha glucosidase (rhGAA) with PS or immunosuppressant dexamethasone resulted in lower anti-rhGAA antibodies than in animals receiving rhGAA alone. However, upon rechallenge with rhGAA, only PS-rhGAA pre-exposed mice displayed a durable hyporesponsiveness even after PS administration was ceased. Thus, pre-exposure of antigens administered together with PS were not silently cleared, but the immune system acquired memory about the antigen that averted mounting of a response during rechallenge. In hemophilia A mice, PS hyporesponsiveness toward Factor VIII was reversed by administration of function-blocking antibody against the PS receptor T-cell immunoglobulin and mucin 4, implicating this receptor in PS's effect. Moreover, pre-exposure of myelin oligodendrocyte glycoprotein peptide with PS delayed the onset and reduced the severity of experimental autoimmune encephalomyelitis. These observations suggest that PS's function in apoptosis is not limited to silent antigen clearance without immune responses toward self-proteins but shows that PS reduces immune response during rechallenge to several antigens that also involves initiation of antigen tolerance.
Copyright © 2018 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  apoptosis; biotechnology; immune response; liposomes; phospholipids; proteins

Mesh:

Substances:

Year:  2018        PMID: 29649469      PMCID: PMC6047910          DOI: 10.1016/j.xphs.2018.03.027

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  39 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Effect of Biophysical Properties of Phosphatidylserine Particle on Immune Tolerance Induction Toward Factor VIII in a Hemophilia A Mouse Model.

Authors:  Radha Ramakrishnan; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2016-07-16       Impact factor: 3.534

Review 3.  The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.

Authors:  Andrew P Robinson; Christopher T Harp; Avertano Noronha; Stephen D Miller
Journal:  Handb Clin Neurol       Date:  2014

4.  New FDA draft guidance on immunogenicity.

Authors:  Ashwin Parenky; Heather Myler; Lakshmi Amaravadi; Karoline Bechtold-Peters; Amy Rosenberg; Susan Kirshner; Valerie Quarmby
Journal:  AAPS J       Date:  2014-03-29       Impact factor: 4.009

5.  Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade.

Authors:  Raymond J Kelleher; Sathy Balu-Iyer; Jenni Loyall; Anthony J Sacca; Gautam N Shenoy; Peng Peng; Vandana Iyer; Anas M Fathallah; Charles S Berenson; Paul K Wallace; Joseph Tario; Kunle Odunsi; Richard B Bankert
Journal:  Cancer Immunol Res       Date:  2015-06-25       Impact factor: 11.151

Review 6.  The distribution and function of phosphatidylserine in cellular membranes.

Authors:  Peter A Leventis; Sergio Grinstein
Journal:  Annu Rev Biophys       Date:  2010       Impact factor: 12.981

7.  Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation.

Authors:  Yi Yin; Xianming Huang; Kristi D Lynn; Philip E Thorpe
Journal:  Cancer Immunol Res       Date:  2013-08-19       Impact factor: 11.151

8.  Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes.

Authors:  S Marin-Gallen; X Clemente-Casares; R Planas; I Pujol-Autonell; J Carrascal; J Carrillo; R Ampudia; J Verdaguer; R Pujol-Borrell; F E Borràs; M Vives-Pi
Journal:  Clin Exp Immunol       Date:  2009-12-17       Impact factor: 4.330

9.  Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums.

Authors:  Kodi S Ravichandran
Journal:  J Exp Med       Date:  2010-08-30       Impact factor: 14.307

Review 10.  Phospholipids: key players in apoptosis and immune regulation.

Authors:  Ricardo A Chaurio; Christina Janko; Luis E Muñoz; Benjamin Frey; Martin Herrmann; Udo S Gaipl
Journal:  Molecules       Date:  2009-11-30       Impact factor: 4.411

View more
  5 in total

1.  Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model.

Authors:  Fiona Y Glassman; Sathy V Balu-Iyer
Journal:  Int J Pharm       Date:  2018-07-05       Impact factor: 5.875

2.  Tolerogenic form of Factor VIII to prevent inhibitor development in the treatment of Hemophilia A.

Authors:  Nhan H Nguyen; Robert K Dingman; Sathy V Balu-Iyer
Journal:  J Thromb Haemost       Date:  2021-09-01       Impact factor: 16.036

Review 3.  Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles.

Authors:  Fiona Y Glassman; Robert Dingman; Helena C Yau; Sathy V Balu-Iyer
Journal:  Immunol Invest       Date:  2020-03-23       Impact factor: 3.657

4.  Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments.

Authors:  Maulasri Bhatta; Gautam N Shenoy; Jenni L Loyall; Brian D Gray; Meghana Bapardekar; Alexis Conway; Hans Minderman; Raymond J Kelleher; Beatriz M Carreno; Gerald Linette; Leonard D Shultz; Kunle Odunsi; Sathy V Balu-Iyer; Koon Yan Pak; Richard B Bankert
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751

Review 5.  Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments.

Authors:  Gautam N Shenoy; Maulasri Bhatta; Richard B Bankert
Journal:  Cells       Date:  2021-11-13       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.